Perioperative Quality Initiative (POQI) consensus statement on fundamental concepts in perioperative fluid management: fluid responsiveness and venous capacitance
- PMID: 32337020
- PMCID: PMC7171743
- DOI: 10.1186/s13741-020-00142-8
Perioperative Quality Initiative (POQI) consensus statement on fundamental concepts in perioperative fluid management: fluid responsiveness and venous capacitance
Abstract
Background: Optimal fluid therapy in the perioperative and critical care settings depends on understanding the underlying cardiovascular physiology and individualizing assessment of the dynamic patient state.
Methods: The Perioperative Quality Initiative (POQI-5) consensus conference brought together an international team of multidisciplinary experts to survey and evaluate the literature on the physiology of volume responsiveness and perioperative fluid management. The group used a modified Delphi method to develop consensus statements applicable to the physiologically based management of intravenous fluid therapy in the perioperative setting.
Discussion: We discussed the clinical and physiological evidence underlying fluid responsiveness and venous capacitance as relevant factors in fluid management and developed consensus statements with clinical implications for a broad group of clinicians involved in intravenous fluid therapy. Two key concepts emerged as follows: (1) The ultimate goal of fluid therapy and hemodynamic management is to support the conditions that enable normal cellular metabolic function in order to produce optimal patient outcomes, and (2) optimal fluid and hemodynamic management is dependent on an understanding of the relationship between pressure, volume, and flow in a dynamic system which is distensible with variable elastance and capacitance properties.
Keywords: Fluid responsiveness; Goal-directed fluid therapy; Perioperative fluid management; Physiology; Venous capacitance.
© The Author(s) 2020.
Conflict of interest statement
Competing interestsGSM - none; DAK - grant funding and travel reimbursement for Cheetah Medical, Advisory Board and speaker honoraria for Pulsion Medical Systems; PEM - advisory board and research funding from Baxter; NS - none ; DL - none; JW – none; DBM – none; DC - Speakers Bureau for Edwards Lifesciences, Medtronic; JL – none; TW – none; KM – none; MLNGM – xxx; TMW – none; DM – consultant for Edwards Lifesciences and Siemens Healthineers; CHEI – none; MWM – none; HH – none; MPWG – research funding from Sphere Medical Ltd (UK) and Pharmacosmos Ltd (UK), advisory board of Sphere Medical Ltd.; MGM - University Chair Sponsor at UCL by Smiths Medical, Director Evidence Based Perioperative Medicine (EBPOM) Community Interest Company (CiC), Director Medinspire Ltd (Patent holder “QUENCH”), Paid consultant for Edwards Lifesciences and Baxter; TJG - Consultant for Acacia, Edwards Lifesciences, Mallinckrodt, Medtronic and Merck; TEM – research funding and consultant for Edwards Lifesciences.
Figures






References
-
- Drummond JC. The lower limit of autoregulation: time to revise our thinking? Anesthesiol. 1997;86:1411–1433. - PubMed
LinkOut - more resources
Full Text Sources